Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Vascular Biogenics (VBLT)

Vascular Biogenics Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:VBLT
DateTimeSourceHeadlineSymbolCompany
19/09/202420:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBLTVascular Biogenics Ltd
16/09/202420:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBLTVascular Biogenics Ltd
29/08/202420:06Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:VBLTVascular Biogenics Ltd
26/08/202420:34Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBLTVascular Biogenics Ltd
14/08/202420:31Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VBLTVascular Biogenics Ltd
09/08/202420:01Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:VBLTVascular Biogenics Ltd
06/08/202421:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBLTVascular Biogenics Ltd
24/07/202411:40Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBLTVascular Biogenics Ltd
19/07/202420:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBLTVascular Biogenics Ltd
01/07/202421:19Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:VBLTVascular Biogenics Ltd
20/06/202421:01Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:VBLTVascular Biogenics Ltd
10/05/202421:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VBLTVascular Biogenics Ltd
10/05/202421:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VBLTVascular Biogenics Ltd
10/05/202421:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VBLTVascular Biogenics Ltd
10/05/202421:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VBLTVascular Biogenics Ltd
10/05/202421:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VBLTVascular Biogenics Ltd
10/05/202421:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VBLTVascular Biogenics Ltd
06/05/202420:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBLTVascular Biogenics Ltd
19/04/202420:56Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:VBLTVascular Biogenics Ltd
12/04/202412:44Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBLTVascular Biogenics Ltd
11/04/202421:00Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:VBLTVascular Biogenics Ltd
09/04/202421:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBLTVascular Biogenics Ltd
08/04/202416:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBLTVascular Biogenics Ltd
01/04/202420:30Edgar (US Regulatory)Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405NASDAQ:VBLTVascular Biogenics Ltd
25/03/202413:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBLTVascular Biogenics Ltd
22/02/202413:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBLTVascular Biogenics Ltd
22/02/202413:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBLTVascular Biogenics Ltd
16/02/202414:00Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:VBLTVascular Biogenics Ltd
05/02/202422:00Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:VBLTVascular Biogenics Ltd
02/02/202421:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBLTVascular Biogenics Ltd
 Showing the most relevant articles for your search:NASDAQ:VBLT